Rimiterol
Chemical compound
- AU: A
- R03AC05 (WHO)
- AU: S4 (Prescription only)
- 4-{(S)-hydroxy[(2R)-piperidin-2-yl]methyl}benzene-1,2-diol
- 32953-89-2 N
- 36283
- 33366 Y
- 26GIW6ZLPH
- ChEMBL1097630 N
- DTXSID70186603
- Interactive image
- O[C@@H](c1ccc(O)c(O)c1)[C@@H]2NCCCC2
InChI
- InChI=1S/C12H17NO3/c14-10-5-4-8(7-11(10)15)12(16)9-3-1-2-6-13-9/h4-5,7,9,12-16H,1-3,6H2/t9-,12+/m1/s1 Y
- Key:IYMMESGOJVNCKV-SKDRFNHKSA-N Y
Rimiterol (INN/USAN) is a third-generation[1] short-acting[2][3] β2 agonist.
See also
- Isoprenaline
- Colterol
References
- ^ Palma-Carlos AG, Palma-Carlos GS (April 1986). "Beta-2-agonists of third generation". Allergie et Immunologie. 18 (4): 31–2, 35. PMID 2899434.
- ^ Lai CK, Twentyman OP, Holgate ST (October 1989). "The effect of an increase in inhaled allergen dose after rimiterol hydrobromide on the occurrence and magnitude of the late asthmatic response and the associated change in nonspecific bronchial responsiveness". The American Review of Respiratory Disease. 140 (4): 917–23. doi:10.1164/ajrccm/140.4.917. PMID 2572192.
- ^ Ydreborg SO, Svedmyr N, Thiringer G (April 1977). "Comparison of rimiterol and terbutaline, given by aerosol, in a long-term study". Scandinavian Journal of Respiratory Diseases. 58 (2): 117–24. PMID 16339.
- v
- t
- e
Short-acting β2 agonists | |
---|---|
Long-acting β2 agonists |
|
Ultra-long-acting β2 agonists | |
Other |
muscarinic antagonist
Leukotriene antagonists | |
---|---|
Arachidonate 5-lipoxygenase inhibitors | |
Thromboxane receptor antagonists | |
Non-xanthine PDE4 inhibitors |
- Aclidinium bromide/formoterol
- Beclometasone/formoterol
- Beclometasone/formoterol/glycopyrronium bromide
- Budesonide/formoterol
- Budesonide/glycopyrronium bromide/formoterol
- Fluticasone furoate/umeclidinium bromide/vilanterol
- Fluticasone furoate/vilanterol
- Fluticasone propionate/salmeterol
- Glycopyrronium bromide/formoterol
- Indacaterol/glycopyrronium bromide
- Indacaterol/glycopyrronium bromide/mometasone
- Indacaterol/mometasone
- Ipratropium bromide/salbutamol
- Mometasone/formoterol
- Salbutamol (albuterol)/budesonide
- Theophylline/ephedrine
- Theophylline/ephedrine/hydroxyzine
- Theophylline/ephedrine/phenobarbital
- Umeclidinium bromide/vilanterol
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
This drug article relating to the respiratory system is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e